Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Equity (2016 - 2025)

Historic Return on Equity for Iovance Biotherapeutics (IOVA) over the last 12 years, with Q3 2025 value amounting to 0.57%.

  • Iovance Biotherapeutics' Return on Equity fell 400.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.57% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Return on Equity stood at 0.57%, which was down 400.0% from 0.53% recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Return on Equity registered a high of 0.28% during Q1 2023, and its lowest value of 0.71% during Q1 2024.
  • In the last 3 years, Iovance Biotherapeutics' Return on Equity had a median value of 0.53% in 2024 and averaged 0.53%.
  • Data for Iovance Biotherapeutics' Return on Equity shows a peak YoY increase of 2000bps (in 2024) and a maximum YoY decrease of -4300bps (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Iovance Biotherapeutics' Return on Equity stood at 0.71% in 2023, then rose by 29bps to 0.5% in 2024, then dropped by -13bps to 0.57% in 2025.
  • Its last three reported values are 0.57% in Q3 2025, 0.53% for Q2 2025, and 0.51% during Q1 2025.